Conning Inc. Catalent, Inc. Transaction History

Conning Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$109.17 - $142.35 $201,964 - $263,347	-1,850 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$100.34 - $115.69 $19,064 - $21,981	-190 Reduced 9.31%	1,850 $200,000
Q1 2021 Apr 23, 2021	SELL	$101.51 - $125.27 $4,060 - $5,010	-40 Reduced 1.92%	2,040 $215,000
Q4 2020 Jan 28, 2021	BUY	$85.88 - $105.36 $178,630 - $219,148	2,080 New	2,080 $216,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

Stay updated on Conning Inc. with notifications on news.